Business Context and Reporting Period
Company: Gladstone Capital Corporation (GLAD)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2008
Business Model: Closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and Regulated Investment Company (RIC). The company invests primarily in debt securities of established private businesses.
Key Financial Metrics
| Metric | Q4 2008 | Q4 2007 |
|---|---|---|
| Net Investment Income | $5,881,000 | $7,303,000 |
| Net (Decrease) Increase in Net Assets from Operations | $(9,103,000) | $1,900,000 |
| Net Assets (Total) | $253,790,000 | $271,748,000 |
| Net Asset Value (NAV) per Share | $12.04 | $12.89 |
| Market Price per Share (End of Period) | $8.09 | $17.01 |
| Total Investments at Fair Value | $384,578,000 | $407,933,000 |
| Borrowings under Line of Credit | $146,470,000 | $161,831,000 |
| Asset Coverage Ratio | 273% | 264% |
| Cash and Cash Equivalents | $5,756,000 | $6,493,000 |
Material Changes vs. Prior Period
- Operating Loss: The company reported a net decrease in net assets from operations of $9.1 million, a significant reversal from the $1.9 million increase in the prior year. This was driven primarily by a net unrealized depreciation on investments of $13.3 million (compared to $5.4 million in Q4 2007) and a net realized loss on the sale of investments of $1.7 million.
- Portfolio Valuation: Total investments at fair value declined from $407.9 million to $384.6 million. The portfolio was valued at approximately 85% of cost due to market instability and illiquidity in the syndicated loan market.
- Non-Accrual Status: Three investments (Greatwide Logistics, LYP Holdings, and U.S. Healthcare) were placed on non-accrual status, totaling approximately $9.2 million in cost basis (2.0% of total portfolio cost).
- Expense Increases: Operating expenses increased to $5.9 million (net of credits) from $4.1 million. This included a significant rise in the amortization of deferred financing fees ($719,000 vs. $74,000) due to amendments to the credit facility.
- Stock Performance: The market price of common stock fell to $8.09, trading at a 33% discount to the NAV of $12.04.
Guidance, Outlook, Risks, and Unusual Items
- Valuation Methodology Change: Due to market illiquidity, the company adopted FASB Staff Position No. 157-3, utilizing internally-developed discounted cash flow (DCF) methodologies for approximately 15% of the portfolio ($57.7 million) where indicative bid prices were deemed unreliable.
- Liquidity and Financing Risk: The company's $300 million revolving credit facility (DB Facility) matures on May 21, 2009. Management highlighted significant risk regarding the renewal or replacement of this facility given deteriorating credit markets. Failure to renew could force asset sales at disadvantageous terms.
- Equity Issuance Constraints: Because the stock trades below NAV, the company is restricted under the 1940 Act from issuing new equity to the public without stockholder approval. A proposal to allow sales below NAV for one year is scheduled for the annual meeting on February 19, 2009.
- Distributions: The company maintained monthly distributions of $0.14 per share. However, estimates indicate a portion of these distributions may be characterized as a return of capital rather than ordinary income.
- Fee Waivers: The Adviser voluntarily and irrevocably waived the entire incentive fee and reduced the base management fee on senior syndicated loans to 0.5% (from 2.0%) for the quarter.
Investor Verification Checklist
- Credit Facility Renewal: Verify the status of the $300 million DB Facility renewal prior to its May 21, 2009 maturity, as failure to renew poses a severe liquidity risk.
- Stockholder Approval: Monitor the outcome of the February 19, 2009, annual meeting regarding the proposal to sell shares below NAV, which is critical for future capital raising.
- Non-Accrual Portfolio: Review the performance and recovery prospects of the three non-accrual investments (Greatwide, LYP Holdings, U.S. Healthcare) which represent a material portion of the portfolio's risk.
- Valuation Sensitivity: Assess the impact of continued market illiquidity on the DCF valuations used for syndicated loans, as realized losses upon sale could exceed current unrealized depreciation.
- Distribution Characterization: Confirm the final tax characterization of distributions (ordinary income vs. return of capital) once the fiscal year ends, as interim estimates may change.